ArticleMolecular therapy. Oncology2026

Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids.

Madeleine Birgersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.